Comprehensive transcriptomics and proteome analysis to identify prognostic risk factors for MYCN non-amplified high-risk neuroblastoma. [PDF]
Liu S, Wang Z, Shen J, Li L, Lin Y.
europepmc +1 more source
Spinal low-grade ependymal tumors harboring telomerase reverse transcriptase promoter mutation and chromosome 7 gain with methylation profile of spinal subependymoma. [PDF]
Nagashima Y +12 more
europepmc +1 more source
ZRANB1 depletion inhibits neuroblastoma progression by destabilizing MYCN through EZH2-mediated deubiquitination. [PDF]
Wang Z, Cheng L, Li G, Cheng H.
europepmc +1 more source
Expanding the MYCN Variant Spectrum in Feingold Syndrome Type 1: A Novel N-Terminal Missense Variant Segregating in an Affected Family. [PDF]
Javier Mérida De la Torre F +2 more
europepmc +1 more source
Repurposing MK0873 as a non-covalent hTERT-Targeting compound: a proof of concept study. [PDF]
Ansari M +5 more
europepmc +1 more source
<i>Mycn</i> Reactivates the Cell Cycle in Adult Cardiomyocytes and Promotes Cardioprotection in Myocardial Infarction. [PDF]
Hirofuji A +11 more
europepmc +1 more source
A Bayesian-Based Integrative Bioinformatics Analysis Nominates Oncogenic Drivers in Neuroblastoma. [PDF]
Xu L +14 more
europepmc +1 more source
A rare case of intradural extramedullary anaplastic ependymoma: a 35-month survival update following resection and adjuvant proton beam radiation therapy. Illustrative case. [PDF]
Ezzat B +5 more
europepmc +1 more source
Nitidine chloride suppresses polo-like kinase 1 via MYCN-associated transcriptional regulation in colorectal cancer: a multi-omics and spatial transcriptomics study. [PDF]
Huang XJ +6 more
europepmc +1 more source

